135 related articles for article (PubMed ID: 12361743)
1. Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma.
Zhu Z; Vachareau A; Neirinck L
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):297-306. PubMed ID: 12361743
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometry.
Gupta VK; Jain R; Lukram O; Agarwal S; Dwivedi A
Talanta; 2011 Jan; 83(3):709-16. PubMed ID: 21147310
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatography-mass spectrometric analysis of ramipril and its active metabolite ramiprilat in human serum: application to a pharmacokinetic study in the Chinese volunteers.
Lu XY; Shen-Tu JZ; Liu J
J Pharm Biomed Anal; 2006 Feb; 40(2):478-83. PubMed ID: 16181761
[TBL] [Abstract][Full Text] [Related]
4. Interference from a glucuronide metabolite in the determination of ramipril and ramiprilat in human plasma and urine by gas chromatography-mass spectrometry.
Persson BA; Fakt C; Ervik M; Ahnoff M
J Pharm Biomed Anal; 2006 Feb; 40(3):794-8. PubMed ID: 16242284
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of UPLC tandem mass spectrometry assay for separation of a phase II metabolite of ramipril using actual study samples and its application to a bioequivalence study.
Pudage A; Kamat S
Biomed Chromatogr; 2011 Jun; 25(6):664-73. PubMed ID: 20812207
[TBL] [Abstract][Full Text] [Related]
6. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG
J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554
[TBL] [Abstract][Full Text] [Related]
7. Impact of methylation of acyl glucuronide metabolites on incurred sample reanalysis evaluation: ramiprilat case study.
Côté C; Lahaie M; Latour S; Bergeron M; Dicaire C; Savoie N; Furtado M; Garofolo F
Bioanalysis; 2011 May; 3(9):951-65. PubMed ID: 21545343
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat after intravenous and oral doses of ramipril in healthy horses.
Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Serrano Caballero JM; Muñoz A
Vet J; 2016 Feb; 208():38-43. PubMed ID: 26639833
[TBL] [Abstract][Full Text] [Related]
9. Lack of male-female differences in disposition and esterase hydrolysis of ramipril to ramiprilat in healthy volunteers after a single oral dose.
Vree TB; Dammers E; Ulc I; Horkovics-Kovats S; Ryska M; Merkx ; Ijsbrand
ScientificWorldJournal; 2003 Dec; 3():1332-43. PubMed ID: 14755115
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic parameters of ramipril and ramiprilat in healthy dogs and dogs with reduced glomerular filtration rate.
Lefebvre HP; Jeunesse E; Laroute V; Toutain PL
J Vet Intern Med; 2006; 20(3):499-507. PubMed ID: 16734081
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
Desmoulins PO; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
[TBL] [Abstract][Full Text] [Related]
12. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
Levitt DG; Schoemaker RC
BMC Clin Pharmacol; 2006 Jan; 6():1. PubMed ID: 16398929
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence study of 10 mg ramipril tablets in healthy Thai volunteers.
Chatsiricharoenkul S; Thangboonjit W; Pongnarin P; Konhan K; Sathirakul K; Kongpatanakul S
J Med Assoc Thai; 2011 Oct; 94(10):1260-6. PubMed ID: 22145513
[TBL] [Abstract][Full Text] [Related]
14. Multiple-dose pharmacokinetics of ramipril in patients with chronic congestive heart failure.
Heintz B; Verho M; Brockmeier D; Lückel G; Maigatter S; Sieberth HG; Rangoonwala B; Bender N
J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S36-42. PubMed ID: 7514239
[TBL] [Abstract][Full Text] [Related]
15. Determination of ramipril in human plasma and its fragmentation by UPLC-Q-TOF-MS with positive electrospray ionization.
Szpot P; Buszewicz G
Acta Pharm; 2015 Jun; 65(2):159-69. PubMed ID: 26011932
[TBL] [Abstract][Full Text] [Related]
16. Kinetics, safety, and efficacy of ramipril after long-term administration in hemodialyzed patients.
Fillastre JP; Baguet JC; Dubois D; Vauquier J; Godin M; Legallicier B; Luus HG; de la Rey N; Carcone N; Genthon R
J Cardiovasc Pharmacol; 1996 Feb; 27(2):269-74. PubMed ID: 8720427
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition in cirrhotic patients--pharmacokinetics of ramipril.
Pidlich J; Cichini GM; Reinisch W; Peck-Radosavljevic M; Renner F
Acta Med Austriaca; 1997; 24(1):15-8. PubMed ID: 9150805
[TBL] [Abstract][Full Text] [Related]
18. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study.
Jain DS; Subbaiah G; Sanyal M; Pande UC; Shrivastav P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):92-100. PubMed ID: 16709467
[TBL] [Abstract][Full Text] [Related]
19. Lack of interaction between ramipril and simvastatin.
Meyer BH; Scholtz HE; Müller FO; Luus HG; de la Rey N; Seibert-Grafe M; Eckert HG; Metzger H
Eur J Clin Pharmacol; 1994; 47(4):373-5. PubMed ID: 7875191
[TBL] [Abstract][Full Text] [Related]
20. Bioanalytical method development and validation using incurred samples--simultaneous quantitation of ramipril and ramiprilat in human EDTA plasma by LC-MS/MS.
Tan A; Jin W; Deng F; Hussain S; Musuku A; Massé R
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3673-80. PubMed ID: 19782651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
